Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xeloda and Paclitaxel in Gastric Cancer With Liver Metastasis
NCT01167049Phase 2Unknown
- Sponsor
- Peking University Cancer Hospital & Institute
- Start
- Aug 2009
- Primary completion
- Dec 2013
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of capecitabine, paclitaxel in gastric cancer (GC), sponsored by Peking University Cancer Hospital & Institute. Status: unknown.
02
Drugs
capecitabinepaclitaxel
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT01167049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01167049.